Monoclonal Antibodies Market Size | Insights, Trends & Growth Analysis 2025

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA10171

Publication Date: Oct 2025

What is the size of Monoclonal Antibodies Market?

According to 6Wresearch internal database and industry insights, the Monoclonal Antibodies Market was valued at USD 132.7 Billion in 2024 and is expected to reach USD 295.4 Billion by 2031, growing at a CAGR of 12.1% during 2025-2031.

The main factors for this growth include the increasing prevalence of chronic diseases, higher demand for targeted therapies, and ongoing advancements in monoclonal antibody therapies in areas such as oncology, immunology, and infectious disease.

Growth Factors for Monoclonal Antibodies Industry

Increase in the prevalence of cancer and autoimmune diseases resulting in the demand for monoclonal antibody-based therapies.
Increase in the demand for personalised medicine and targeted therapies.
Advancement in biomanufacturing and antibody engineering technologies.
Increase in public funding for cancer research and development of new therapy drugs.
Increase in the adoption of monoclonal antibody use for the treatment of infectious diseases.

Monoclonal Antibodies Market Trends

The Monoclonal Antibodies Market is rapidly changing towards the development of bispecific antibodies and antibody-drug conjugates (ADCs) for improved targeted therapies. The advancement of biologic manufacturing processes, including the use of biosimilars, also provides more access and affordability of treatments. There is further movement towards combination therapies involving monoclonal antibodies and other treatment modalities to improve outcomes and efficacy.

Emerging Developments in the Monoclonal Antibodies Market

The Monoclonal Antibodies Market is experiencing several developments, including the rise of next-generation monoclonal antibodies with enhanced potency and minimal side effects. Companies are also investing in innovative drug delivery methods, such as subcutaneous administration, to improve patient convenience and adherence. Furthermore, the market is witnessing breakthroughs in the treatment of rare diseases, with monoclonal antibodies playing a critical role in developing personalized therapies for conditions that currently have limited treatment options.